Lombard Odier Asset Management (USA)’s Intersect ENT, Inc XENT Stock Holding History

Lombard Odier Asset Management (USA)’s Portfolio XENT Stock Details XENT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-90,000	Closed	-$2.05M	–	318
2019 Q2	$2.05M	Buy	90,000 +25,000	+38%	+$674K	0.16%	140
2019 Q1	$2.09M	Sell	65,000 -30,000	-32%	-$928K	0.17%	128
2018 Q4	$2.68M	Sell	95,000 -145,000	-60%	-$4.25M	0.21%	113
2018 Q3	$6.9M	Buy	+240,000	New	+$7.21M	0.51%	63

Other funds holding XENT

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Lombard Odier Asset Management (USA)'s XENT Position: Q3 2019 in Review

Lombard Odier Asset Management (USA) sold out of Intersect ENT, Inc (XENT) in Q3 2019, closing a stake of 90,000 shares — an estimated $2.05M sold.

Lombard Odier Asset Management (USA) first reported a position in XENT in Q3 2018 and held it in 4 quarters. The position peaked at $6.9M in Q3 2018. 112 funds tracked by Wall St. Rank hold XENT as of Q3 2019.

Lombard Odier Asset Management (USA) reported no remaining Intersect ENT, Inc position as of Q3 2019 after selling out during the quarter.
Lombard Odier Asset Management (USA) sold 90,000 Intersect ENT, Inc shares in Q3 2019, an estimated $2.05M.
Lombard Odier Asset Management (USA) first reported a position in Intersect ENT, Inc in Q3 2018 and held it in 4 quarters.
Lombard Odier Asset Management (USA)'s Intersect ENT, Inc position peaked at $6.9M in Q3 2018.
112 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q3 2019.

Based on Lombard Odier Asset Management (USA)'s 13F filing for Q3 2019, filed 14 Nov 2019.